๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical significance and implication of neoangiogenesis in hepatocellular carcinoma

โœ Scribed by James O Park; Matthew M Yeh

Book ID
108954100
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
97 KB
Volume
26
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Clinical significance of early hepatocel
Clinical significance of early hepatocellular carcinoma
โœ Kazuto Inoue; Tadatoshi Takayama; Tokio Higaki; Yoshihiro Watanabe; Masatoshi Ma ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 71 KB

Early hepatocellular carcinoma (HCC) is defined as a well-differentiated cancer containing Glisson's triad, but it remains unknown whether this lesion is curable by surgery. We studied 70 patients who had a single HCC smaller than 2 cm in diameter (Stage T1) and who underwent curative hepatectomy an

Fibronectin patterns in hepatocellular c
Fibronectin patterns in hepatocellular carcinoma and its clinical significance
โœ Jaishree Jagirdar; Kamal G. Ishak; Massimo Colombo; Carla Brambilla; Fiorenzo Pa ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 684 KB

Fibronectin, a high molecular weight glycoprotein component of the extracellular matrix, was localized extracellularly and intracellularly in the nuclei and the cytoplasm of hepatocellular carcinomas (HCC) by the use of the biotin-avidin method on paraffin-embedded, pepsin-treated tissue. The specif

Biological markers in hepatocellular car
Biological markers in hepatocellular carcinoma: Potential clinical implications
โœ Dr. Rosella Silvestrini; Aurora Costa; Antonia D'Errico; Alessandra Faranda; Enr ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 212 KB

The assessment of biological markers as potential indicators of disease aggressiveness is still an open problem in hepatocellular carcinoma. Cell proliferation and extracellular matrix (ECM)-associated antigens and tumor-cell products can be associated with clinical aggressiveness in this tumor type